Bioqual Inc. (OTCMKTS:BIOQ – Get Free Report) was down 7.2% during mid-day trading on Wednesday. The company traded as low as $30.64 and last traded at $30.64. Approximately 900 shares changed hands during trading, an increase of 33,862% from the average daily volume of 3 shares. The stock had previously closed at $33.00.
Bioqual Stock Down 7.2%
The company has a market cap of $27.27 million, a price-to-earnings ratio of -7.03 and a beta of -0.10. The company’s 50-day moving average is $32.86 and its 200 day moving average is $33.70.
Bioqual (OTCMKTS:BIOQ – Get Free Report) last released its quarterly earnings data on Monday, September 21st. The company reported ($2.81) earnings per share for the quarter. The firm had revenue of $9.27 million during the quarter. Bioqual had a negative net margin of 9.75% and a negative return on equity of 11.20%.
Bioqual Company Profile
Bioqual, Inc is a biomedical research and contract research organization based in Rockville, Maryland. The company provides preclinical research services to pharmaceutical and biotechnology companies, government agencies, and other organizations involved in the development of medical products.
Its work focuses primarily on infectious diseases, vaccines, therapeutics, and diagnostics. Bioqual conducts laboratory and animal-model studies designed to evaluate the safety, efficacy, immunology, virology, and pharmacology of potential treatments and preventive products.
Further Reading
- Five stocks we like better than Bioqual
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
